Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 325 clinical trials
None
Multi-Centre Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients

biotherapeutic products. The first bevacizumab biosimilar in China was launched in December 2019. Although monoclonal antibody biosimilar drugs are similar to the original drug in terms of quality, safety and

  • 0 views
  • 22 Aug, 2021
  • 2 locations
None
Ocular Blood Flow in Colorectal Cancer Patients

In colorectal cancer therapy anti-angiogenic strategies have become a cornerstone of treatment regimens in the metastatic setting. Addition of bevacizumab to conventional chemotherapeutic

bevacizumab
  • 1 views
  • 07 Sep, 2021
  • 1 location
None
Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers

of anti-VEGF (bevacizumab, ranibizumab and aflibercept) against these choroidal neovessels. However, some eyes appear to respond less well or be resistant to anti-VEGF injections, which affects

  • 0 views
  • 26 Jan, 2021
  • 1 location
None
A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT After Initial Ate/Bev

The treatment strategies for HCC with PVTT is still controversial, and differ substantially between the west and the east. According to western guidelines, including those of the EASL, BCLC, and AASLD, PVTT is regarded as a contra-indication to initial surgery or transarterial chemoembolization. HCC with PVTT consists of heterogeneous populations …

  • 0 views
  • 13 Jun, 2021
  • 1 location
None
The Gene Profiles of Primary and Heterogeneous Metastases of Colorectal Cancer

The incidence and mortality of colorectal cancer in China's cancer disease spectrum is on the rise, and it is a common malignant tumor that harms the health of Chinese residents.In patients with synchronous metastatic colorectal cancer, RAS status is highly consistent in primary focus and metastasis, so NCCN guidelines recommend …

metastasis
aptt
metastatic colorectal adenocarcinoma
neutrophil count
adenocarcinoma
  • 0 views
  • 24 Jan, 2021
  • 1 location
None
Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer

To assess the safety profile of bevacizumab in combination with chemotherapy for the treatment of metastatic colorectal cancer

bevacizumab
  • 12 views
  • 07 Nov, 2020
  • 6 locations
None
An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer

treatment (mFOLFOX6 + bevacizumab versus mFOLFOX6 + panitumumab therapy) and check if the study treatment improves symptoms of advanced/recurrent colorectal cancer.

  • 0 views
  • 16 Oct, 2021
  • 1 location
None
Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about the effect of bevacizumab and VEGF on platelet clustering. PURPOSE

cancer
  • 0 views
  • 07 Nov, 2020
  • 1 location
None
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

VEGFRs may be the biomarker which can predict the effect of bevacizumab in non small cell lung cancer

metastasis
bevacizumab
cancer chemotherapy
lung carcinoma
measurable disease
  • 8 views
  • 08 Nov, 2020
  • 1 location
None
Bevacizumab Plus EGFR-TKIs in Chinese Patients With EGFR-mutant NSCLC: a Real-world Study

This study is a prospective, multicenter, real-world study to investigate the efficacy and safety of bevacizumab plus epidermal growth factor (EGFR) Tyrosine Kinase Inhibitors in Chinese

icotinib
egfr t790m
erlotinib
growth factor
bevacizumab
  • 0 views
  • 26 Jan, 2021
  • 1 location